Skip to main content

Chronic Wound Care Market to Reach USD 16.36 Billion by 2027; Presence of Several Large Scale Healthcare Companies will Bode well for Market Growth, says Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, India, Jan. 21, 2021 (GLOBE NEWSWIRE) — The global chronic wound care market size is projected to reach USD 16.36 billion by the end of 2027. The increasing investment in the technological integration will open up a huge potential for the growth of the overall market. According to a report published by Fortune Business Insights, the market was worth USD 10.12 billion in 2019 and will exhibit a CAGR of 6.2% during the forecast period, 2020-2027. As of 2019, the market in North America was worth 3.87 billion and this value is projected to increase at a considerable pace in the coming years.Chronic wounds are diseases that haven’t been successfully treated during the process of treatment of repair. The costs associated with chronic wounds are much higher than normal disease treatment. According to data published by the US National Library of Medicine, in 2018, around 5.7 million people in the United States suffered from chronic wound diseases. The high prevalence of the disease will create several growth opportunities for the companies operating in the market.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/chronic-wound-care-market-100222
KEY INDUSTRY DEVELOPMENTS:April 2019 – Smith & Nephew acquired Osiris Therapeutics Inc., in order to diversify its products offerings and strengthen its position in the chronic wound care segmentMay 2018 – Coloplast Corp announced the launch of Biatain Silicone with 3Dfit technology in order to offer wide range of product portfolio in foam dressing segmentDecrease in Hospital Visits During Covid-19 Pandemic will have an Adverse Effect on Market GrowthThe recent coronavirus outbreak has instilled a sense of panic and confusion among people across the globe. The rapid spread of the disease has compelled people to stay indoors. Moreover, governments of several countries across the world have taken several efforts to curb the spread of the disease; lockdown and social distancing being the most effective measures. As a result, the number of hospital visits during the pandemic has gone down significantly. This factor will negatively affect the chronic wound care market in the immediate future.
Click here to get the short-term and long-term impacts of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/industry-reports/chronic-wound-care-market-100222
Constant Product Innovations will Provide Impetus to Market GrowthThe report encompasses several factors that have contributed to the growth of the overall market in recent years. Accounting to the rising prevalence of chronic diseases across the world, several large scale companies are looking to invest more in product innovations with a bid to acquiring a wider consumer base.The increasing investments in product innovations will bode well for the growth of the overall market in the coming years. In February 2019, Axio Biosolutions Pvt. Ltd. announced the launch of a new advanced dressing made from an advanced product.
Quick Buy –  Chronic Wound Care Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100222
North America Likely to Emerge Dominant; Presence of Several Health Reimbursement Policies will Bode Well for Market GrowthThe report analyses the latest market trends across five major regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among all regions, the market in North America is projected to emerge dominant in the coming years. The high prevalence of chronic diseases, especially in the Unites States, will create several growth opportunities for the companies operating in this region.Moreover, the presence of adequate health reimbursement policies will lead to a wider adoption of chronic wound care in this region. As of 2019, the market in North America was worth 3.87 billion and this value is projected to increase at a considerable pace in the coming years. The market in Asia Pacific is projected to register a high CAGR in the coming years, driven by the presence of several large scale companies in countries such as India and China.
List of companies profiled in the report:Smith & Nephew (London, U.K.)Cardinal Health (Dublin, Ohio)Coloplast Corp (Humlebaek, Denmark)ConvaTec Inc. (England, U.K.)Mölnlycke Health Care AB (Gothenburg, Sweden)Integra LifeSciences Corporation (New Jersey, U.S.)3M (Minnesota, U.S)B. Braun Melsungen AG (Melsungen, Germany)Tissue Regenix (West Yorkshire, U.S)Other Players
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/chronic-wound-care-market-100222
Market Segmentations:By Type•              Diabetic Ulcers•              Pressure Ulcers•              Venous Ulcers•              Arterial UlcersBy Product•              Advanced Wound Dressings•              Wound Care Devices•              Active Therapy•              OthersBy End User•              Hospitals & Wound Care Centers•              Homecare Settings & OthersBy Geography•              North America (U.S. and Canada)•              Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)•              Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)•              Latin America (Brazil, Mexico, and Rest of Latin America)•              The Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/chronic-wound-care-market-100222
SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companiesDetails in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facilityNumber of procedures and average price of proceduresReplacement rate and pricing of capital equipmentMarket dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunitiesMarket & technological trends, new product developments, product pipeline.
Have a Look at Related Reports:Human Insulin Market Share & Industry Analysis, By Type (Analogue Insulin, Traditional Human Insulin), By Diabetes Type (Type 1, Type 2), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), and Regional Forecast, 2019-2026Influenza Vaccine Market Share & Industry Analysis, By Type (Inactivated and Live Attenuated), By Valency (Quadrivalent and Trivalent), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Geography Forecast, 2019-2026Autotransfusion Devices Market Share & Industry Analysis, By Product Type (Autotransfusion Systems and Consumables & Accessories) By Application (Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics & Gynecological Surgeries, and Others) By End User (Hospitals and Specialty Clinics & Others) and Regional Forecast, 2019-2026Trauma Implants Market Share & Industry Analysis, By Product (Metal Plates & Screws, Pins/Wires, Nails & Rods, and Others) End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others) and Regional Forecast, 2019-2026Idiopathic Inflammatory Myopathy Treatment Market Share & Industry Analysis, By Disease Type (Dermatomyositis, Polymyositis, Necrotizing Autoimmune Myopathy, Others), By Treatment (Corticosteroids, Immunosuppressants, Others), By Route of Administration (Oral, Intravenous, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/global-chronic-wound-care-market-10131

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.